Vigil Neuroscience Inc Sustainability Reports
Vigil Neuroscience, Inc. is a clinical-stage biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases. The company develops therapeutics designed to restore the functionality and vigilance of microglia, the brain's sentinel immune cells.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00YGBK4R3
3 reports from 2022 to 2024